The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 19, 2025
Filed:
Apr. 30, 2020
Applicant:
Sitryx Therapeutics Limited, Oxford, GB;
Inventors:
Michael Liam Cooke, Nottingham, GB;
David Cousin, Nottingham, GB;
Matthew Colin Thor Fyfe, Oxfordshire, GB;
Barry John Teobald, Oxfordshire, GB;
Stephen Malcolm Thom, Nottingham, GB;
Thomas Michael Waugh, Nottingham, GB;
Assignee:
Sitryx Therapeutics Limited, Oxford, GB;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/225 (2006.01); A61K 31/275 (2006.01); A61K 31/337 (2006.01); A61K 31/341 (2006.01); A61K 31/351 (2006.01); A61K 31/38 (2006.01); A61K 31/397 (2006.01); A61K 31/4015 (2006.01); A61K 31/41 (2006.01); A61K 31/445 (2006.01); A61K 31/46 (2006.01); A61K 31/495 (2006.01); A61K 31/5375 (2006.01); A61K 31/54 (2006.01); C07C 69/593 (2006.01); C07C 219/08 (2006.01); C07C 233/05 (2006.01); C07C 255/14 (2006.01); C07C 311/03 (2006.01); C07C 317/18 (2006.01); C07D 205/04 (2006.01); C07D 207/27 (2006.01); C07D 207/273 (2006.01); C07D 207/277 (2006.01); C07D 211/96 (2006.01); C07D 257/04 (2006.01); C07D 295/08 (2006.01); C07D 295/088 (2006.01); C07D 305/08 (2006.01); C07D 307/20 (2006.01); C07D 309/12 (2006.01); C07D 331/04 (2006.01); C07D 451/10 (2006.01); C07D 519/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/225 (2013.01); A61K 31/275 (2013.01); A61K 31/337 (2013.01); A61K 31/341 (2013.01); A61K 31/351 (2013.01); A61K 31/38 (2013.01); A61K 31/397 (2013.01); A61K 31/4015 (2013.01); A61K 31/41 (2013.01); A61K 31/445 (2013.01); A61K 31/46 (2013.01); A61K 31/495 (2013.01); A61K 31/5375 (2013.01); A61K 31/54 (2013.01); C07C 69/593 (2013.01); C07C 219/08 (2013.01); C07C 233/05 (2013.01); C07C 255/14 (2013.01); C07C 311/03 (2013.01); C07C 317/18 (2013.01); C07D 205/04 (2013.01); C07D 207/27 (2013.01); C07D 207/273 (2013.01); C07D 207/277 (2013.01); C07D 211/96 (2013.01); C07D 257/04 (2013.01); C07D 295/08 (2013.01); C07D 295/088 (2013.01); C07D 305/08 (2013.01); C07D 307/20 (2013.01); C07D 309/12 (2013.01); C07D 331/04 (2013.01); C07D 451/10 (2013.01); C07D 519/00 (2013.01); C07C 2601/18 (2017.05); C07C 2602/50 (2017.05);
Abstract
The invention relates to compounds of formula (IW-1) and to their use in treating or preventing an inflammatory disease or a disease associated with an undesirable immune response: wherein R, R, Rand Rare as defined herein.